These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3293334)

  • 21. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A; Alam SI; Dhaked RK; Singh L
    Indian J Med Res; 2006 Sep; 124(3):355-62. PubMed ID: 17085839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on immunity to toxins of Clostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin.
    FIOCK MA; YARINSKY A; DUFF JT
    J Bacteriol; 1961 Jul; 82(1):66-71. PubMed ID: 13699727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.
    Hasegawa K; Watanabe T; Sato H; Sagane Y; Mutoh S; Suzuki T; Yamano A; Kouguchi H; Takeshi K; Kamaguchi A; Fujinaga Y; Oguma K; Ohyama T
    Protein J; 2004 Aug; 23(6):371-8. PubMed ID: 15517984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal growth temperature, sodium chloride tolerance, pH sensitivity, and toxin production of marine and terrestrial strains of Clostridium botulinum type C.
    Segner WP; Schmidt CF; Boltz JK
    Appl Microbiol; 1971 Dec; 22(6):1025-9. PubMed ID: 4944801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new scaleable method for the purification of botulinum neurotoxin type E.
    Gessler F
    J Biotechnol; 2005 Sep; 119(2):204-11. PubMed ID: 15885835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and purification of Clostridium botulinum type C and D neurotoxin.
    Gessler F; Böhnel H
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):361-7. PubMed ID: 10397323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependence of Clostridium botulinum gas and protease production on culture conditions.
    Montville TJ
    Appl Environ Microbiol; 1983 Feb; 45(2):571-5. PubMed ID: 6338828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.
    Sugiyama H; Moberg LJ; Messer SL
    Appl Environ Microbiol; 1977 Apr; 33(4):963-6. PubMed ID: 405926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.
    Ohishi I; Sakaguchi G
    Infect Immun; 1980 May; 28(2):303-9. PubMed ID: 7399665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of an esterase-active enzyme from pronase with special reference to activation of Clostridium botulinum type E progenitor toxin.
    Miura T
    Jpn J Med Sci Biol; 1974 Dec; 27(6):285-96. PubMed ID: 4619406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of water activity and pH on growth and toxin production by Clostridium botulinum type G.
    Briozzo J; de Lagarde EA; Chirife J; Parada JL
    Appl Environ Microbiol; 1986 Apr; 51(4):844-8. PubMed ID: 3518631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium botulinum type D neurotoxin: purification and detection.
    De Jongh KS; Schwartzkoff CL; Howden ME
    Toxicon; 1989; 27(2):221-8. PubMed ID: 2655181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clarification regarding novel Clostridium botulinum toxin.
    Korch G
    J Infect Dis; 2014 Nov; 210(9):1517. PubMed ID: 24808390
    [No Abstract]   [Full Text] [Related]  

  • 38. Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin.
    Ciccarelli AS; Whaley DN; McCroskey LM; Gimenez DF; Dowell VR; Hatheway CL
    Appl Environ Microbiol; 1977 Dec; 34(6):843-8. PubMed ID: 74236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The production of Clostridium botulinum toxin in mammalian, avian and piscine carrion.
    Smith GR; Turner A
    Epidemiol Infect; 1989 Jun; 102(3):467-71. PubMed ID: 2661255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.